FTC monitoring how drug companies react to patent cliff, official says
By Jody Godoy PHILADELPHIA, March 17 (Reuters) - The U.S. Federal Trade Commission is on the lookout for anticompetitive practices in the pharmaceutical industry with a number of blockbuster drugs near the end of their patents, the FTC's head of …